GlassScriptPhysician profile
Edward B Li
NPI 1003443532
$4,721.67
in general payments reported to CMS, 2019-2025
13 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $354 · 2022: $853 · 2023: $2,852 · 2024: $508 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,890 · Food and Beverage: $1,624.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,890.00 |
| Food and Beverage | $1,624.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $2,107.36 | 2023 | |
| Abbvie INC. | $807.40 | 2021-2024 | |
| Lilly USA, LLC | $591.44 | 2022-2025 | Taltz, Olumiant, Ebglyss |
| Pfizer INC. | $399.04 | 2024-2025 | |
| Dermavant Sciences, INC. | $167.03 | 2023 | Vtama |
| Novartis Pharmaceuticals Corporation | $133.55 | 2022 | |
| Kyowa Kirin, INC. | $132.61 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2023 | Spevigo |
| Vyne Pharmaceuticals INC. | $118.06 | 2021 | |
| Janssen Biotech, INC. | $69.95 | 2021 | |
| Arcutis Biotherapeutics, INC. | $35.05 | 2024 | Zoryve |
| Epi Health, LLC | $30.00 | 2022 | |
| Organon LLC | $5.18 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.